Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AuraSense is a private digital health company developing physics-informed AI and point-of-care tools that convert human movement and neurological examination data into quantitative clinical insights. The company focuses on neurology care, rehabilitation, and related health applications, while its current website also positions the technology more broadly across sports, gaming, entertainment, and clinical research. Its products appear to combine motion capture, biomechanics, haptics, and machine learning to support motor-function assessment, treatment feedback, and remote or digitally enabled care workflows. AuraSense is an early-stage healthcare technology company rather than a therapeutics developer, and there is no evidence of a traditional drug pipeline or clinical-stage pharmaceutical programs. The business appears to be active and privately held.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AuraSense.